Iron Chelation Therapy as a Modality of Management.

导出原文传递

翻译打印收藏纠错

作者： Yesim,Aydinok ^[1]

作者单位： Department of Pediatric Hematology and Oncology, Ege University Children's Hospital, Bornova, Izmir 35100, Turkey. Electronic address: yesim.aydinok@yahoo.com. ^[1]

关键词 Cardiac iron Chelation Liver iron concentration Non-transfusion dependent thalassemia Serum ferritin Thalassemia intermedia Thalassemia major Transfusion-dependent thalassemia

主题词输血(Blood Transfusion);螯合疗法(Chelation Therapy);内分泌系统疾病(Endocrine System Diseases);人类(Humans);铁(Iron);铁螯合剂(Iron Chelating Agents);铁超负荷(Iron Overload);肝(Liver);磁共振成像(Magnetic Resonance Imaging);地中海贫血(Thalassemia)

DOI 10.1016/j.hoc.2017.12.002

PMID 29458731

发布时间 2018-12-11

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览7

Hematology/oncology clinics of North America

2018年32卷2期

261-275页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Iron Chelation Therapy as a Modality of Management.

Hematology/oncology clinics of North America

相似文献

Hematology/oncology clinics of North America

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Iron Chelation Therapy as a Modality of Management.

Hematology/oncology clinics of North America

相似文献

Hematology/oncology clinics of North America

相关期刊

检索历史清除